S.27 - Preserve Access to Affordable Generics Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
|Version||Word Count||Changes From Previous Version||Percent Change|
|Introduced in Senate||3,199||n/a||n/a|
|Reported in Senate||3,278||7||2%|
Key: changed or removed text inserted or modified text
Most commented sections:
Loading Bill Text
Rollover any line of text to comment and/or link to it.